Pervistop®
Product description
The food supplement for the management of persistent HPV infections.
One clinical trial demonstrated a clearance of HPV in 85% of patients after 3 months of administration. One case report and one in-vitro study further support safety and efficacy, while there are two ongoing clinical trials.
Read more
Specifications
Categories | Food Supplements / Nutraceuticals |
---|---|
Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
Supplied from | Italy |
Product Applications | Dietary Supplements; Food Supplements |
Product Certifications | Quality assurance |
More products from LO.LI. PHARMA INTERNATIONAL S.R.L.
Pervistop®